In terms of the association between risk genes and risk stratification, we discovered that the expression levels of GDF1 and IL5RA genes in low-risk AML patients were increased compared to those in HR and standard risk groups, while the expression levels of PSMD4, DHCR24, and IL12RB2 genes in low-risk AML patients were lower (Figure 7(a)). The gene discussed is IL5RA; the disease is acute myeloid leukemia.